JP2010531293A5 - - Google Patents

Download PDF

Info

Publication number
JP2010531293A5
JP2010531293A5 JP2009553349A JP2009553349A JP2010531293A5 JP 2010531293 A5 JP2010531293 A5 JP 2010531293A5 JP 2009553349 A JP2009553349 A JP 2009553349A JP 2009553349 A JP2009553349 A JP 2009553349A JP 2010531293 A5 JP2010531293 A5 JP 2010531293A5
Authority
JP
Japan
Prior art keywords
group
glycyl
phenylalanyl
salt
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009553349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010531293A (ja
JP5653043B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009553349A priority Critical patent/JP5653043B2/ja
Priority claimed from JP2009553349A external-priority patent/JP5653043B2/ja
Publication of JP2010531293A publication Critical patent/JP2010531293A/ja
Publication of JP2010531293A5 publication Critical patent/JP2010531293A5/ja
Application granted granted Critical
Publication of JP5653043B2 publication Critical patent/JP5653043B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009553349A 2007-06-26 2008-06-26 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体 Expired - Fee Related JP5653043B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009553349A JP5653043B2 (ja) 2007-06-26 2008-06-26 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007167207 2007-06-26
JP2007167207 2007-06-26
JP2009553349A JP5653043B2 (ja) 2007-06-26 2008-06-26 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体
PCT/JP2008/062033 WO2009001968A1 (en) 2007-06-26 2008-06-26 Benzazepine derivatives useful as vasopressin antagonists

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2014130327A Division JP5893085B2 (ja) 2007-06-26 2014-06-25 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体
JP2014130326A Division JP5689195B2 (ja) 2007-06-26 2014-06-25 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体

Publications (3)

Publication Number Publication Date
JP2010531293A JP2010531293A (ja) 2010-09-24
JP2010531293A5 true JP2010531293A5 (OSRAM) 2013-02-07
JP5653043B2 JP5653043B2 (ja) 2015-01-14

Family

ID=39773045

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009553349A Expired - Fee Related JP5653043B2 (ja) 2007-06-26 2008-06-26 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体
JP2014130326A Expired - Fee Related JP5689195B2 (ja) 2007-06-26 2014-06-25 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体
JP2014130327A Expired - Fee Related JP5893085B2 (ja) 2007-06-26 2014-06-25 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014130326A Expired - Fee Related JP5689195B2 (ja) 2007-06-26 2014-06-25 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体
JP2014130327A Expired - Fee Related JP5893085B2 (ja) 2007-06-26 2014-06-25 バソプレシン拮抗剤として使用されるベンゾアゼピン誘導体

Country Status (27)

Country Link
US (3) US8669229B2 (OSRAM)
EP (3) EP2170831B1 (OSRAM)
JP (3) JP5653043B2 (OSRAM)
KR (1) KR101487201B1 (OSRAM)
CN (3) CN103342679A (OSRAM)
AR (1) AR067176A1 (OSRAM)
AT (1) ATE545633T1 (OSRAM)
AU (1) AU2008269918B2 (OSRAM)
BR (1) BRPI0813768A2 (OSRAM)
CA (1) CA2690335A1 (OSRAM)
CO (1) CO6160295A2 (OSRAM)
CY (3) CY1113519T1 (OSRAM)
DK (3) DK2170831T3 (OSRAM)
ES (3) ES2380085T3 (OSRAM)
HR (3) HRP20120310T1 (OSRAM)
IL (1) IL202561A0 (OSRAM)
MY (3) MY148312A (OSRAM)
NZ (3) NZ581723A (OSRAM)
PH (2) PH12012501363A1 (OSRAM)
PL (3) PL2170831T3 (OSRAM)
PT (3) PT2170831E (OSRAM)
RU (1) RU2471784C2 (OSRAM)
SG (2) SG182230A1 (OSRAM)
SI (3) SI2374797T1 (OSRAM)
TW (1) TWI459947B (OSRAM)
UA (1) UA98966C2 (OSRAM)
WO (1) WO2009001968A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
JP5656399B2 (ja) * 2008-12-26 2015-01-21 大塚製薬株式会社 医薬及び医薬製剤
CN102030709B (zh) * 2009-09-25 2013-10-16 江苏豪森医药集团有限公司 用作加压素受体拮抗剂的苯并氮杂卓类化合物
EA022253B1 (ru) * 2009-10-26 2015-11-30 Оцука Фармасьютикал Ко., Лтд. Соединение бензазепина и его применения
GB201105537D0 (en) 2011-03-31 2011-05-18 Vantia Ltd New process
CN102260213B (zh) * 2011-05-31 2013-05-15 重庆福安药业(集团)股份有限公司 一种托伐普坦的制备方法
TWI704919B (zh) * 2012-05-31 2020-09-21 日商大塚製藥股份有限公司 用於預防及/或治療多囊性腎臟病之藥物
CA2894516A1 (en) 2012-12-28 2014-07-03 Otsuka Pharmaceutical Co., Ltd. Injectable depot formulation comprising optically active tolvaptan and process of producing the same
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
TWI660748B (zh) * 2013-03-01 2019-06-01 日商大塚製藥股份有限公司 用於口服投藥之包含非晶型托伐普坦（Ｔｏｌｖａｐｔａｎ）的懸浮液
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
US11911369B2 (en) * 2015-03-03 2024-02-27 Biohaven Therapeutics Ltd. Prodrugs of riluzole and their method of use
WO2019003433A1 (ja) * 2017-06-30 2019-01-03 大塚製薬株式会社 ベンゾアゼピン誘導体
CN107540672A (zh) * 2017-10-10 2018-01-05 牡丹江医学院 一种治疗肝硬化的药物及其合成方法
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
JP2020011957A (ja) * 2019-07-22 2020-01-23 コルセア ファーマ インコーポレイテッド トレプロスチニル誘導体化合物およびその使用方法
CN112851583B (zh) * 2021-01-19 2023-09-08 徐州医科大学 新型苯并氮杂䓬类化合物、组合物及其用途
TW202246216A (zh) 2021-02-10 2022-12-01 大陸商上海森輝醫藥有限公司 苯并氮雜環庚烯類化合物及其製備方法和醫藥用途
CN113112528A (zh) * 2021-04-26 2021-07-13 中南财经政法大学 异常行为监控方法、装置、设备及存储介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045478A (en) * 1986-03-03 1991-09-03 Becton Dickinson And Company Vesicles and use thereof in an assay
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
CA2116334A1 (en) 1992-07-02 1994-01-20 Hidenori Ogawa Oxytocin antagonist
TW270927B (OSRAM) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
GB9726695D0 (en) 1997-12-17 1998-02-18 Smithkline Beecham Plc Novel compounds
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
CN1165532C (zh) 1998-09-29 2004-09-08 惠氏控股有限公司 作为蛋白质酪氨酸激酶抑制剂的取代的3-氰基喹啉
US6642270B2 (en) * 2000-05-15 2003-11-04 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
CN101374539A (zh) * 2004-11-02 2009-02-25 夏尔有限责任公司 改善肝脏递送的利巴韦林前药
ES2533007T3 (es) * 2005-12-27 2015-04-06 Otsuka Pharmaceutical Co., Ltd. Compuesto de benzoacepina soluble en agua y su composición farmacéutica
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑

Similar Documents

Publication Publication Date Title
JP2010531293A5 (OSRAM)
JP2011512324A5 (OSRAM)
WO2008108380A3 (en) Pyrrole compounds
EP1857446A4 (en) NEW HSP90 INHIBITOR
WO2010053583A3 (en) Small molecule cd4 mimetics and uses thereof
JP2005289914A5 (OSRAM)
WO2009016462A3 (en) Substituted bicyclolactam compounds
EA201070786A1 (ru) Бензофуропиримидиноны
WO2008006043A3 (en) 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents
WO2008108386A1 (ja) 医薬組成物
JP2011154353A5 (OSRAM)
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2007056281A3 (en) Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
JP2013528602A5 (OSRAM)
JP2008546770A5 (OSRAM)
JP2014526533A5 (OSRAM)
JP2010155827A5 (OSRAM)
WO2008003854A3 (fr) Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
EA201000393A1 (ru) Новые соединения как антагонисты аденозинового рецептора а1
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
WO2009063990A1 (ja) ベンズアゼピノン化合物
MX2010001566A (es) Derivado de aminopirazolamida.
WO2008149834A1 (ja) ピリミドジアゼピノン誘導体
JP2010534246A5 (OSRAM)
EA201001348A1 (ru) Пирролопиримидинкарбоксамиды